Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

This study is testing an educational tool designed to help melanoma patients who also have an autoimmune disease (like Crohn's, ulcerative colitis, or rheumatoid arthritis) understand the risks and benefits of immune checkpoint inhibitor therapy — a type of cancer immunotherapy. **You may be eligible if...** - You have been diagnosed with melanoma - You also have a pre-existing autoimmune disease such as inflammatory bowel disease (Crohn's or ulcerative colitis), rheumatoid arthritis, or another autoimmune condition **You may NOT be eligible if...** - You do not have both a melanoma diagnosis and a pre-existing autoimmune disease Talk to your doctor to see if this trial is right for you.